Department of Health and Social Care written question – answered at on 28 July 2021.
To ask the Secretary of State for Health and Social Care, what discussions he has had with stakeholders on the recognition of topical steroid withdrawal as an official condition by the NHS.
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the NHS on guidance for GPs and patients on the correct use and dosage of topical steroids.
To ask the Secretary of State for Health and Social Care, whether his Department plans to modify the labelling of topical steroid medications to include clear warnings against over-use.
The Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a review of topical steroid withdrawal. The review is discussing alterations to labelling, guidance and communications with health care professionals. We have consulted on these topics with healthcare experts in the field including those in the National Health Service, patient representatives and other stakeholders. We are considering updates to the product information and further communications to health care professionals and the MHRA expects to issue more information on this in the next few months.
Yes2 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.